Area of research
Neurology · Epidemiology
Research interest
Research interests include Intracerebral and Subarachnoid Hemorrhage Research, Acute Ischemic Stroke Management, Traumatic Brain Injury and Neurovascular Disturbances, and Neurosurgical Procedures and Complications.
A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial
Hydroxyurea to prevent brain injury in children with sickle cell disease (<scp>HU</scp> Prevent)—A randomized, placebo‐controlled phase <scp>II</scp> feasibility/pilot study
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
Neonatal Survival After Serial Amnioinfusions for Bilateral Renal Agenesis
Early antibody treatment, inflammation, and risk of post-COVID conditions
Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Behavioral Phenotyping
Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Neuroimaging
Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical Trials
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling
Mechanical thrombectomy in patients with acute ischemic stroke in the USA before and after time window expansion
Transfusion reactions associated with <scp>COVID</scp>‐19 convalescent plasma in outpatient clinical trials
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial
Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group in the Pediatric Population
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial
Placebo-Controlled Effectiveness of Idiopathic Normal Pressure Hydrocephalus Shunting: A Randomized Pilot Trial
Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis
Design and Protocol of the Renal Anhydramnios Fetal Therapy (RAFT) Trial
How do I implement an outpatient program for the administration of convalescent plasma for <scp>COVID</scp>‐19?
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection
Bayesian deep learning outperforms clinical trial estimators of intracerebral and intraventricular hemorrhage volume
Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage
Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness
Early Inflammatory Cytokine Expression in Cerebrospinal Fluid of Patients with Spontaneous Intraventricular Hemorrhage
Post-Stroke Depression in Patients with Large Spontaneous Intracerebral Hemorrhage
New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases
ASTRO: Adjuvant STeroid Outcomes in idiopathic subglottic stenosis: A randomized trial
Johns Hopkins University Trial Innovation Center
Johns Hopkins University Trial Innovation Center
Johns Hopkins University Trial Innovation Center
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation
JHU Statistical and Safety Resource Center (SSRC)
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial
Collaborative Research: Building Educational Theory Through Enacting Reforms in STEM
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial
Neurometabolic Outcomes of Different Cardiopulmonary Bypass Strategies
Neurometabolic Outcomes of Different Cardiopulmonary Bypass Strategies
Neurometabolic Outcomes of Different Cardiopulmonary Bypass Strategies
Neurometabolic Outcomes of Different Cardiopulmonary Bypass Strategies
Metformin in Alzheimer's dementia Prevention (MAP)